The central role of Fas-ligand cell signaling in inflammatory lung diseases.
about
Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivoAn overview of caspase: Apoptotic protein for silicosisCalcium and ER stress mediate hepatic apoptosis after burn injury.Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.Human-specific bacterial pore-forming toxins induce programmed necrosis in erythrocytesThe effect of infection order of porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus on dually infected swine alveolar macrophages.Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis.Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infectionIron-binding drugs targeted to lysosomes: a potential strategy to treat inflammatory lung disorders.Alterations of Fas and Fas-related molecules in patients with silicosis.Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient miceCysteine cathepsins and caspases in silicosis.Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside.Annexin A5 promotes macrophage activation and contributes to pulmonary fibrosis induced by silica particles.IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways.Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α.Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners.Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury.
P2860
Q24315092-2A287CE8-6B9D-423B-AF14-D86B5D69EFB3Q28384832-C5FB8D04-4978-499B-A6A7-4AC1C6C660E1Q33793882-5A84E845-D895-4533-82F6-879AE45D5D11Q34056050-BDD933AD-DEF2-40B8-B25E-6089D6046C4DQ34237796-19C48AF6-1E17-41C1-AAE2-817BBA0C7F81Q34421167-04E0CDBA-A950-41B1-8C71-EC03509CFD2BQ35094492-48C83F33-8CAA-47D7-A78E-2884558C9DB2Q35097949-DA6C61F0-9920-42A6-BB77-462D389A2ED6Q35928284-6B5540B6-E239-4531-AA56-E4967DE2115AQ36210908-3C854064-21E2-4FE8-A6FB-97CD93E68691Q36459053-0E311438-FA91-4E65-B5F6-B01550D05108Q36462882-9DAE5149-B560-459B-9A45-7657E3ADC1A5Q36567785-E6C07184-16DE-42C2-93CF-1E4F2939EB08Q37427668-9AA34B68-E981-483C-BBAD-B14DF1997447Q38057375-8F8551BE-DE7B-49CF-B329-39A3CFC797A3Q38901583-186B9F85-CD84-494D-B9A1-DC485CCCA894Q39788067-EC86C279-D758-4FD3-ACBF-163B430CC505Q42094948-3EE46579-3084-4E6B-A08F-7B42D168C5A6Q42197114-15BBCA44-3F10-4451-A062-EB976C1AA878Q43186791-FBE25C26-8D1F-47A3-8C17-141A9754B3E1Q54641882-5B26A1C3-2180-4832-A079-B3B8EEA784C7
P2860
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@ast
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@en
type
label
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@ast
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@en
prefLabel
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@ast
The central role of Fas-ligand cell signaling in inflammatory lung diseases.
@en
P2860
P1476
The central role of Fas-ligand cell signaling in inflammatory lung diseases
@en
P2093
P2860
P304
P356
10.1111/J.1582-4934.2004.TB00318.X
P577
2004-07-01T00:00:00Z